| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRVA | Common Stock | Sale | -$69.4M | -2.51M | -8.04% | $27.70 | 28.7M | Nov 23, 2021 | See footnotes | F1, F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. |
| F2 | On May 11, 2021, Brighton Health Group Holdings, LLC made a pro rata distribution of 79,178,464 shares of common stock, par value $0.01 per share (the "Common Stock") of the Issuer to its members, including an aggregate 30,512,093 shares of Common Stock to the GS Funds (as defined below). |
| F3 | Pursuant to an underwriting agreement, dated November 18, 2021 (the "Underwriting Agreement"), the GS Funds (as defined below) offered and sold an aggregate 2,505,732 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 22, 2021, which offering was consummated on November 23, 2021 (the "Offering"). The amount above represents the $29.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $1.305 per share of Common Stock. |
| F4 | As of November 22, 2021, as a result of the Offering, GS Group and Goldman Sachs may be deemed to beneficially own indirectly 28,006,361 shares of Common Stock by reason of Common Stock held by certain investment entities (the "GS Funds") of which Goldman Sachs and GS Group are the general partner, managing limited partner, managing general partner, managing partner, managing member or member. |